U.S., Oct. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07220954) titled 'A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234' on Oct. 23.
Brief Summary: This study in healthy volunteers aims to compare blood levels and side effects after administration of different formulations of AZD6234.
This study will take place at one site in Nottingham, United Kingdom, and will enrol 21 healthy men and women aged 18-55 years.
Study Start Date: Nov. 10
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: AZD6234 Formulation 1
AZD6234 Formulation 1 will be administered as a single SC injection
DRUG: AZD6234 Formulation 2 (low concentration...